Publications by authors named "Imerio Capone"

Claim this Profile
M
Machine Learning Reassessment of Serum Immune Factors Shows No Unique Immune Profiles Linked to Disease Outcomes in SARS-CoV-2-infected Patients at Hospital Admittance.
Stefania Rossi, Imerio Capone, Enrico Cabri, Anna Giabelli, Ilaria Rossoni

Eur J Immunol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NSD2 and miRNAs as Key Regulators of Melanoma Response to Romidepsin and Interferon-α2b Treatment.
Alessandro De Santis, Lucrezia De Santis, Francesca Rossi, Silvia Gasparini, Valerio Licursi, Imerio Capone

Cancer Med· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD8+CD103+PD1+TIM3+ T cells in glioblastoma microenvironment correlate with prognosis.
Giulia Romagnoli, Quintino Giorgio D'Alessandris, Imerio Capone, Andrea Tavilla, Irene Canini

Immunology· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reversing vemurafenib-resistance in primary melanoma cells by combined romidepsin and type I IFN treatment through blocking of tumorigenic signals and induction of immunogenic effects.
Alessandra Fragale, Emilia Stellacci, Giulia Romagnoli, Valerio Licursi, Stefania Parlato, Imerio Capone

Int J Cancer· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Type I IFN-dependent antibody response at the basis of sex dimorphism in the outcome of COVID-19.
Lucia Gabriele, Alessandra Fragale, Giulia Romagnoli, Stefania Parlato, Caterina Lapenta, Imerio Capone

Cytokine Growth Factor Rev· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and Immunological Outcomes in High-Risk Resected Melanoma Patients Receiving Peptide-Based Vaccination and Interferon Alpha, With or Without Dacarbazine Preconditioning: A Phase II Study.
Francesca Urbani, Virginia Ferraresi, Imerio Capone, Iole Macchia, Belinda Palermo

Front Oncol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Type I Interferons and Cancer: An Evolving Story Demanding Novel Clinical Applications.
Eleonora Aricò, Luciano Castiello, Imerio Capone, Lucia Gabriele, Filippo Belardelli

Cancers (Basel)· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and Antitumor Immune Responses in Relapsed/Refractory Follicular Lymphoma Patients after Intranodal Injections of IFNα-Dendritic Cells and Rituximab: a Phase I Clinical Trial.
M Christina Cox, Luciano Castiello, Mauro Mattei, Laura Santodonato, Giuseppina D'Agostino, Imerio Capone

Clin Cancer Res· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sexual Dimorphism of Immune Responses: A New Perspective in Cancer Immunotherapy.
Imerio Capone, Paolo Marchetti, Paolo Antonio Ascierto, Walter Malorni, Lucia Gabriele

Front Immunol· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antitumor Effects of Epidrug/IFNα Combination Driven by Modulated Gene Signatures in Both Colorectal Cancer and Dendritic Cells.
Alessandra Fragale, Giulia Romagnoli, Valerio Licursi, Maria Buoncervello, Giorgia Del Vecchio, Imerio Capone

Cancer Immunol Res· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IFN-α potentiates the direct and immune-mediated antitumor effects of epigenetic drugs on both metastatic and stem cells of colorectal cancer.
Maria Buoncervello, Giulia Romagnoli, Mariachiara Buccarelli, Alessandra Fragale, Elena Toschi, Imerio Capone

Oncotarget· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intratumoral injection of IFN-alpha dendritic cells after dacarbazine activates anti-tumor immunity: results from a phase I trial in advanced melanoma.
Carmela Rozera, Giancarlo Antonini Cappellini, Giuseppina D'Agostino, Laura Santodonato, Luciano Castiello, Imerio Capone

J Transl Med· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of type I interferon in inducing a protective immune response: perspectives for clinical applications.
Paola Rizza, Franca Moretti, Imerio Capone, Filippo Belardelli

Cytokine Growth Factor Rev· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploiting dendritic cells in the development of cancer vaccines.
Laura Bracci, Imerio Capone, Federica Moschella, Enrico Proietti, Filippo Belardelli

Expert Rev Vaccines· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploitation of the propulsive force of chemotherapy for improving the response to cancer immunotherapy.
Enrico Proietti, Federica Moschella, Imerio Capone, Filippo Belardelli

Mol Oncol· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IFN-α as a vaccine adjuvant: recent insights into the mechanisms and perspectives for its clinical use.
Paola Rizza, Imerio Capone, Franca Moretti, Enrico Proietti, Filippo Belardelli

Expert Rev Vaccines· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination strategies for enhancing the efficacy of immunotherapy in cancer patients.
Federica Moschella, Enrico Proietti, Imerio Capone, Filippo Belardelli

Ann N Y Acad Sci· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recombinant interferon-alpha2b improves immune response to hepatitis B vaccination in haemodialysis patients: results of a randomised clinical trial.
María E Miquilena-Colina, Tamara Lozano-Rodríguez, Leonor García-Pozo, Alicia Sáez, Paola Rizza, Imerio Capone

Vaccine· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemotherapy enhances vaccine-induced antitumor immunity in melanoma patients.
Paola Nisticò, Imerio Capone, Belinda Palermo, Duilia Del Bello, Virginia Ferraresi

Int J Cancer· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dendritic cells and cytokines in immune rejection of cancer.
Maria Ferrantini, Imerio Capone, Filippo Belardelli

Cytokine Growth Factor Rev· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the effects of human leukocyte IFN-alpha on the immune response to the HBV vaccine in healthy unvaccinated individuals.
Paola Rizza, Imerio Capone, Francesca Urbani, Enrica Montefiore, Maria Rapicetta

Vaccine· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interferon-alpha and cancer: mechanisms of action and new perspectives of clinical use.
Maria Ferrantini, Imerio Capone, Filippo Belardelli

Biochimie· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
International meeting "Immunotherapy of cancer: challenges and needs".
Maria Ferrantini, Imerio Capone, Francesco M Marincola, Giorgio Parmiani, Filippo Belardelli

Cancer Immunol Immunother· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunization of stage IV melanoma patients with Melan-A/MART-1 and gp100 peptides plus IFN-alpha results in the activation of specific CD8(+) T cells and monocyte/dendritic cell precursors.
Tiziana Di Pucchio, Lorenzo Pilla, Imerio Capone, Maria Ferrantini, Enrica Montefiore

Cancer Res· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytokines as natural adjuvants for vaccines: where are we now?
Paola Rizza, Maria Ferrantini, Imerio Capone, Filippo Belardelli

Trends Immunol· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis